Insurance flip flop hurts vulnerable seniors
By Kenneth E. Thorpe
The vast majority of seniors have at least one chronic condition, and more than two thirds have two or more chronic conditions, so choosing the right coverage is important.
Fortunately, premium prices are expected to remain stable. But out-of-pocket pharmacy costs are expected to rise, thanks almost entirely to the benefit design set by many insurance plans. To keep premiums low, insurers are saddling sick enrollees with higher out-of-pocket bills.
Increasing out-of-pocket expenses for patients with multiple chronic conditions is counterproductive.
Higher cost-sharing reduces the likelihood of adherence to medication regimens, thus aggravating people’s underlying health problems and driving up costs elsewhere in the healthcare system.
Research shows that non-adherence causes at least 10 percent of hospitalizations and costs the rest of the healthcare system upwards of $289 billion annually. It also puts a higher cost burden on those who need help the most: Research has shown that for the sickest, a $1 increase in copayments results in a $1.78 increase in overall healthcare spending. This especially hurts seniors with multiple chronic conditions.
Healthcare plans are supposed to shield patients from financial ruin when disease strikes. Since the Affordable Care Act took effect, insurers have been prohibited from denying insurance to anyone. Beneficiaries pay a monthly premium with the understanding that their individual health dollars support a larger “risk” pool. Those who are healthy thus subsidize those who are sick, knowing that if they themselves fall ill, they’ll be protected.
When it comes to prescription drug coverage, however, insurers increasingly flip this dynamic. They’re effectively raising costs on the sickest individuals to offer savings to healthy enrollees.
Here’s how. Pharmaceutical companies offer large discounts to health insurers to ensure their drugs are covered by health plans. In Medicare, for example, brand-name drugs are discounted by 30 percent, on average. Last year, the pharmaceutical industry paid out $153 billion in total discounts and rebates.
Insurers keep some of these rebates for themselves and use the rest to lower premiums. That’s good news for healthy enrollees.
But these discounts are not shared directly with patients at the pharmacy. Most insurers require patients to pay co-insurance on brand-name drugs, which is a set percentage of a drug’s sticker, or “list,” price rather than a percentage of the discounted price the insurer pays.
As a result, sicker patients who fill lots of prescriptions rarely benefit from the massive discounts granted by drug companies. This isn’t how insurance is supposed to work.
The Trump administration recognizes that drug benefit design is undermining the foundational promise of insurance. In its 2019 budget, the administration put forward a plan that would require insurers in the Medicare drug benefit to share a portion of negotiated discounts with patients at the point of sale.
These are encouraging developments. Unless insurers share discounts directly with patients, high cost-sharing requirements will continue to prevent sick enrollees from taking their prescriptions as directed. That means worse health outcomes for those patients and higher spending for the Medicare program, and thus taxpayers.
Kenneth E. Thorpe is a professor of health policy at Emory University and chairman of the Partnership to Fight Chronic Disease.
The viewpoints expressed above are those of the author and do not necessarily reflect those of The Independent.
How to submit an article, guest opinion piece, or letter to the editor to The Independent
Do you have something to say? Want your voice to be heard by thousands of readers? Send The Independent your letter to the editor or guest opinion piece. All submissions will be considered for publication by our editorial staff. If your letter or editorial is accepted, it will run on suindependent.com, and we’ll promote it through all of our social media channels. We may even decide to include it in our monthly print edition. Just follow our simple submission guidelines and make your voice heard:
—Submissions should be between 300 and 1,500 words.
—Submissions must be sent to editor@infowest.com as a .doc, .docx, .txt, or .rtf file.
—The subject line of the email containing your submission should read “Letter to the editor.”
—Attach your name to both the email and the document file (we don’t run anonymous letters).
—If you have a photo or image you’d like us to use and it’s in .jpg format, at least 1200 X 754 pixels large, and your intellectual property (you own the copyright), feel free to attach it as well, though we reserve the right to choose a different image.
—If you are on Twitter and would like a shout-out when your piece or letter is published, include that in your correspondence and we’ll give you a mention at the time of publication.
Articles related to “Insurance flip flop hurts vulnerable seniors”
Utah ACA enrollment for 2019 rises slightly compared to last year
